The biopharmaceutical industry has been a hotbed of innovation in recent years, with an increasing number of novel recombinant protein therapeutics receiving the U.S. Food and Drug Administration’s (FDA) green light.
Harnessing the Power of Upstream Platform Integration to Accelerate Biopharma Innovation
